Results
Awaiting price reaction for this filing.
Dolphin Medical Services reported Q1 FY26 revenue from operations of Rs. 16.86 lakhs, up about 20% from Rs. 14.05 lakhs in Q1 FY25. Total revenue stood at Rs. 17.78 lakhs versus Rs. 14.97 lakhs a year ago. The company swung to a net profit of Rs. 3.13 lakhs, compared with a profit of Rs. 1.03 lakhs in Q1 FY25 and a loss of Rs. 7 lakhs in the preceding Q4 FY25. EPS came in at Rs. 0.02 versus Rs. 0.01 in the year-ago quarter. However, the full-year FY25 still ended in a loss of Rs. 3.38 lakhs, and reserves remain negative at Rs. (506.04) lakhs, reflecting accumulated losses. The auditor issued a clean limited review report with no qualifications.
A return to profit and double-digit revenue growth are mild positives for shareholders, but the very small absolute revenue base and deeply negative reserves mean the stock remains a high-risk, micro-cap name with limited near-term value impact expected.